Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  Sam68 modulator CWP232291
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Clinical Study of CWP232291 in Relapsed or Refractory Myeloma Patients
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: JW-231MM-102, NCI-2015-01078, NCT02426723
Start Over